Bill Text: TX HB670 | 2019-2020 | 86th Legislature | Comm Sub

---

Bill Title: Relating to health benefit plan coverage for ovarian cancer testing and screening.

Sponsorship: Slight Partisan Bill (Republican 2-1)

Status: (Introduced - Dead) 2019-04-30 - Committee report sent to Calendars [HB670 Detail]

Download: Texas-2019-HB670-Comm_Sub.html

---

86R98 LED-D
By: King of Hemphill, Kacal, H.B. No. 670
J. Johnson of Dallas

A BILL TO BE ENTITLED
AN ACT
relating to health benefit plan coverage for ovarian cancer testing
and screening.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
SECTION 1. Section 1370.003(b), Insurance Code, is amended
to read as follows:
(b) Coverage required under this section includes at a
minimum:
(1) a CA 125 blood test; [and]
(2) a conventional Pap smear screening or a screening
using liquid-based cytology methods, as approved by the United
States Food and Drug Administration, alone or in combination with a
test approved by the United States Food and Drug Administration for
the detection of the human papillomavirus; and
(3) any other test or screening approved by the United
States Food and Drug Administration for the detection of ovarian
cancer.
SECTION 2. Section 1370.003, Insurance Code, as amended by
this Act, applies only to a health benefit plan delivered, issued
for delivery, or renewed on or after January 1, 2020. A health
benefit plan delivered, issued for delivery, or renewed before
January 1, 2020, is governed by the law as it existed immediately
before the effective date of this Act, and that law is continued in
effect for that purpose.
SECTION 3. This Act takes effect September 1, 2019.